Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial

BACKGROUND: Bladder cancer is the tenth most common cancer worldwide. For patients with T1 high-grade or T2 bladder cancer, radical cystectomy is recommended. However, radical cystectomy is associated with various complications and has a detrimental impact on the quality of life. Bladder-sparing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiangwei, Zhang, Shiqiang, Cui, Yajiao, Li, Yamei, Song, Xinyue, Pang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080830/
https://www.ncbi.nlm.nih.gov/pubmed/37024824
http://dx.doi.org/10.1186/s12885-023-10798-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080830/
https://www.ncbi.nlm.nih.gov/pubmed/37024824
http://dx.doi.org/10.1186/s12885-023-10798-2

Ejemplares similares